BioMimetix Pharmaceutical is Biotechnology in United States that focus on side effect business. Founded in 2011. They cover business area such as developer, biopharmaceutical product, cancer, Greenwood Village, Colorado, compound, previous metalloporphyrin antioxidant mimetic, various disease, radiation toxicity, a frequent side effect, radiation therapy, client, inflammatory and neoplastic disease.
2011
( 13 years old in 2024 )
Side Effect
-
5340 South Quebec Street
Suite 345N
Greenwood Village, CO 80111
United States
Private
developerbiopharmaceutical productcancerGreenwood VillageColoradocompoundprevious metalloporphyrin antioxidant mimeticvarious diseaseradiation toxicitya frequent side effectradiation therapyclientinflammatory and neoplastic disease
* We use standard office opening hours in near BioMimetix Pharmaceutical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BioMimetix Pharmaceutical is Biotechnology business from United States that founded in 2011 (13 years old in 2024), BioMimetix Pharmaceutical business is focusing on Side Effect.
BioMimetix Pharmaceutical headquarter office and corporate office address is located in 5340 South Quebec Street Suite 345N Greenwood Village, CO 80111 United States.
BioMimetix Pharmaceutical was founded in United States.
In 2024, BioMimetix Pharmaceutical is currently focus on side effect sector.
Above is snippet of Google Trends for "side effect" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BioMimetix Pharmaceutical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
